Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.

For political, economic and national security reasons, Washington should enable Puerto Rico to resume its place as a major maker of medicines.

Autism Research EXPERT Says Trump’s TYLENOL Claims ‘EXTREME’ & ‘DEVASTATING’ | SUNRISE President Trump’s new pharmaceutical ...

Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness ...

With growing demand for advanced therapies, improved manufacturing processes are needed to provide flexibility and increase ...

Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar deals that would ...

PfizerPFE stock surged Wednesday, pulling shares of AstraZenecaAZN, GSKGSK and NovartisNVS higher, after the Dow Jones ...

President Donald Trump says 100% tariffs on certain pharmaceuticals will take effect next week, but there are several ...

The Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to reach a value of USD 2196 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.95% ...

The announcement comes a day after the drugmaker announced it broke ground on the expansion of a North Chicago plant.

Fluor is set to gain from U.S. pharma reshoring and rising sector investment, with strong fundamentals and value. Learn why ...